FDA Adds Three Chinese Drugmakers to Import Alert Lists
The FDA is continuing its crackdown on Chinese drugmakers, adding three more companies this week to its import alert lists over faulty GMP practices and a refusal for inspection.
Source: Drug Industry Daily